Skip to content

Prognostic Value of Delta LUS Score of Patients Hospitalized for Acute Heart Failure

Prognostic Value of Delta LUS Score of Patients Hospitalized for Acute Heart Failure Within 30 Days of Discharge

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05871138
Acronym
Deltalus
Enrollment
500
Registered
2023-05-23
Start date
2023-03-30
Completion date
2023-12-30
Last updated
2023-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Heart Failure, Emergencies

Keywords

Delta-lus score, heart failure

Brief summary

prognostic value of delta LUS score of patients hospitalized for acute heart failure within 30 days of discharge.

Detailed description

The aim of our study is to evaluate the contribution of the variation of the LUS score performed at the time of admission (LUS1) and at discharge (LUS2) in predicting the clinical course of patients admitted for acute cardiac decompensation 30 days after discharge. Delta LUS score=((LUS2-LUS1) \*100)/LUS1

Interventions

None listed

Sponsors

University of Monastir
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Patients aged over 18 years, * Patients hospitalized in the emergency department for dyspnea having as etiology an acute heart failure and in whom will be performed two pulmonary ultrasound examinations (at entry and exit).

Exclusion criteria

* Age less than 18 years * Dyspnea of non-cardiac etiology (cause: pulmonary, traumatic, toxic...) * Altered state of consciousness (Glasgow score\<14) * Hemodynamic instability: presence of peripheral signs of shock, use of vasoactive drugs * Mechanical ventilation from the outset * Cardiorespiratory arrest * Inability to give consent to the study * Missing one of two ultrasound examinations * Unable to make telephone contact after one month.

Design outcomes

Primary

MeasureTime frameDescription
Delta lus30 daysThe primary outcome evaluate the contribution of the variation of the LUS score performed at the time of admission (LUS1) and at discharge (LUS2) in predicting the clinical course of patients admitted for acute cardiac
Readmission30 daysReadmission

Countries

Tunisia

Contacts

Primary ContactNouira Semir, Pr
semir.nouira@rns.tn73106046
Backup ContactBel Hadj Ali Khaoula, MD
belhadjalikhaoula@yahoo.fr73106046

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026